Jason Mills

Stock Analyst

(4.88)
# 3,205
Out of 4,648 analysts
115
Total ratings
69.23%
Success rate
34.74%
Average return

Stocks Rated by Jason Mills

TransMedics Group
Oct 29, 2024
Maintains: Buy
Price Target: $169$109
Current: $84.35
Upside: +29.22%
Penumbra
Oct 16, 2024
Maintains: Buy
Price Target: $176$235
Current: $229.19
Upside: +2.54%
STAAR Surgical Company
Apr 26, 2022
Maintains: Buy
Price Target: $81$89
Current: $29.36
Upside: +203.13%
AngioDynamics
Jul 14, 2021
Maintains: Hold
Price Target: $24$28
Current: $6.75
Upside: +315.12%
iRhythm Technologies
Nov 6, 2020
Maintains: Buy
Price Target: $236$273
Current: $81.17
Upside: +236.33%
Merit Medical Systems
Oct 29, 2020
Maintains: Buy
Price Target: $51$55
Current: $99.27
Upside: -44.60%
Neuronetics
Oct 26, 2020
Maintains: Buy
Price Target: $4$8
Current: $1.08
Upside: +640.74%
Nevro
Aug 6, 2020
Maintains: Buy
Price Target: $116$153
Current: $5.32
Upside: +2,775.94%
LeMaitre Vascular
Jul 24, 2020
Maintains: Hold
Price Target: $28$30
Current: $95.93
Upside: -68.73%
Intuitive Surgical
Jul 22, 2020
Maintains: Buy
Price Target: $187$242
Current: $508.10
Upside: -52.44%
Maintains: Hold
Price Target: $66$50
Current: $48.88
Upside: +2.30%
Maintains: Buy
Price Target: $41$45
Current: $33.66
Upside: +33.69%
Maintains: Buy
Price Target: $85$62
Current: $15.13
Upside: +309.78%
Maintains: Buy
Price Target: $43$46
Current: $84.65
Upside: -45.66%
Upgrades: Buy
Price Target: n/a
Current: $74.65
Upside: -
Downgrades: Hold
Price Target: $516,000$120,000
Current: $0.79
Upside: +15,286,524.20%